VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

Information Request

Information Request

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

To request information, please fill out and submit the form below:
Copyright © 2005-2023 Vanda Pharmaceuticals Inc. |